AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

AbbVie is striving to outsmart cancer by working with scientists, physicians, industry peers, patient groups and most importantly patients, to discover, develop and provide new medicines that will have a remarkable impact on the lives of people around the world. Our goal is to provide medicines that can lead to improvement in cancer treatment and outcomes for patients. By exploring and investing in new pathways and technologies, AbbVie is breaking ground in some of the most widespread and difficult-to-treat cancers.

Together, we are striving to outsmart cancer.

For further information on the company and its people, portfolio and commitments, please visit